COMMUNIQUÉS West-GlobeNewswire

Cambridge Medical Robotics closes Series A fundraise with further $26 million

18/09/2017 - 08:00

Cambridge Medical Robotics Limited ("CMR" or the "Company") Cambridge Medical Robotics closes Series A fundraise with further $26 million Cambridge, UK, 18 September 2017 : Cambridge Medical Robotics Ltd, the private [...]

Saniona AB: Saniona reports encouraging start for tesofensine Phase 3 study

18/09/2017 - 08:00

PRESS RELEASE September 18, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that Saniona's partner, Medix, has recruited 150 out of the planned 372 patients in the study during the [...]

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

18/09/2017 - 08:00

PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® [...]

ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

18/09/2017 - 07:30

Leuven, Belgium, 18 th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease, announced today that [...]

INNATE PHARMA,: Premier semestre 2017 : Nouvelles données cliniques et enrichissement du portefeuille

18/09/2017 - 07:00

PREMIER SEMESTRE 2017 : NOUVELLES DONNÉES CLINIQUES ET ENRICHISSEMENT DU PORTEFEUILLE Trésorerie, équivalents de trésorerie et actifs financiers [1] s'élevant à 204,1 millions d'euros au 30 juin 2017 Importants progrès [...]

INNATE PHARMA, First half of 2017: delivering key clinical data and strengthening the pipeline

18/09/2017 - 07:00

first half of 2017: DELIVERING KEY CLINICAL Data and strengthening the Pipeline Cash, cash equivalents and financial assets [1] for the Company amounted to €204.1m (million euros) as of June 30, 2017 Significant [...]

Addex Makes Changes to Executive Management Team

18/09/2017 - 07:00

Geneva, Switzerland, 18 September 2017 - Addex Therapeutics (SIX: ADXN) announced today that Robert Lutjens, Head of Discovery will join the Executive Management Team and take over scientific leadership with support [...]

Novartis' Xolair® confirms re-treatment efficacy in chronic spontaneous urticaria patients after treatment interruption

16/09/2017 - 16:00

OPTIMA Phase IIIb data re-confirm that almost two thirds of patients treated with Xolair 300 mg for 6 months are well-controlled[1] Should a treatment pause be necessary, data showed almost 90% of chronic spontaneous [...]

Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis

16/09/2017 - 08:15

Sanofi and Regeneron Announce Positive Study Results for Dupixent ® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis - Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European [...]

Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère

16/09/2017 - 08:15

Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent ® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère - Présentation orale des résultats de l'étude de phase 3 [...]

Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option

15/09/2017 - 19:29

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2017

15/09/2017 - 17:00

Communiqué de presse Villepinte, le 15 septembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Shire Debuts MYDAYIS® and New Research at the 30th Annual Psych Congress

15/09/2017 - 13:00

Shire Debuts MYDAYIS ® and New Research at the 30 th Annual Psych Congress Lexington, MA - September 15, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) will share new Attention Deficit Hyperactivity Disorder (ADHD) research [...]

Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of death

15/09/2017 - 09:31

PR170915_EASD_Tresiba_UK This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Solon Eiendom ASA : Primary insider notification

15/09/2017 - 08:30

(Oslo, Norway, 14 September 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 25 373 shares in Solon Eiendom ASA at a price of NOK 17,5908. Following [...]

Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease

15/09/2017 - 08:00

Press release Malmö, September 15, 2017 Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease The company's roll-out program on track as [...]

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017

15/09/2017 - 08:00

FIT Biotech Oy Company release September 15th, 2017 at 9:00 EET FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017 (unaudited) This company release is a summary of FIT Biotech's Half Year Financial [...]

Herantis Pharma receives Life Sciences Nordic Stars Award

15/09/2017 - 07:30

Herantis Pharma receives Life Sciences Nordic Stars Award Herantis Pharma Plc Press release 15 Sep 2017 at 8:30 am Herantis Pharma plc ("Herantis") received the Nordic Stars Award at the Nordic Life Sciences Days in [...]

Fagron NV: Disclosure of received notification

15/09/2017 - 07:00

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands) 1 , 15 September 2017 Disclosure of received notification Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in [...]